Used in pharmaceutical research as a key intermediate in the synthesis of opioid receptor modulators. Shows potential in the development of analgesic agents with reduced side effects compared to traditional opioids. Investigated for its activity in central nervous system disorders, particularly pain management and addiction treatment. Its structure allows for selective binding to certain opioid subtypes, making it valuable in creating more targeted therapies. Also explored in the design of novel treatments for respiratory depression and gastrointestinal motility issues linked to opioid use.